Understanding how a protein related to Alzheimer's disease functions

Mechanisms of APP ectodomain function

['FUNDING_OTHER'] · OKLAHOMA MEDICAL RESEARCH FOUNDATION · NIH-10862658

This study is looking at how a protein related to Alzheimer's disease affects brain cell communication and memory, with the hope of finding new ways to understand and treat the condition.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorOKLAHOMA MEDICAL RESEARCH FOUNDATION (nih funded)
Locations1 site (OKLAHOMA CITY, UNITED STATES)
Trial IDNIH-10862658 on ClinicalTrials.gov

What this research studies

This research investigates the role of the Amyloid Precursor Protein (APP) and its extracellular domain in cellular processes, particularly in relation to Alzheimer's disease. The study aims to uncover how APP shedding affects cellular signaling and cognitive functions, which could lead to new insights into Alzheimer's pathology. By exploring the interactions of soluble APP fragments with specific receptors, the research seeks to fill knowledge gaps regarding APP's physiological roles. Patients may benefit from a better understanding of Alzheimer's mechanisms, potentially leading to new therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk for developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could provide new insights into Alzheimer's disease mechanisms and lead to innovative treatment options.

How similar studies have performed: Previous research has shown promising results in understanding the roles of similar proteins in neurodegenerative diseases, suggesting potential for success in this area.

Where this research is happening

OKLAHOMA CITY, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.